Brief Definitive Report
TNF receptor associated factor 3 (TRAF3), a member of the TRAF family of intracellular signaling proteins, has multiple effects on signal transduction by the TNF receptor superfamily as well as other receptor families (Häcker, et al., 2011; Hildebrand et al., 2011) . The importance of TRAF3 is highlighted by the finding that general deletion of the traf3 gene results in mouse death within 2 wk of birth (Xu et al., 1996) . Accu mulating data indicate that the role of TRAF3 is highly receptor and cell type dependent. TRAF3 promotes production of type I interferon and IL10 in myeloid cells after TLR stimulation (Häcker et al., 2006; Oganesyan et al., 2006) , whereas it negatively regulates B cell survival and CD40 signaling, as well as TLR signals to B cells Xie et al., 2011b) . TRAF3 also negatively regulates IL17 signaling in myeloid cells by interfering with the forma tion of an IL17R-Act1-TRAF6 complex (Zhu et al., 2010) . Newly identified roles for TRAF3 in T cell biology were revealed recently by our group. Producing and analyzing CD4 Cre Traf3 flox/flox (TTRAF3 / ) mice, we found that deficiency of TRAF3 in mature CD4 + and CD8 + T cells causes defective T cell-dependent antibody production, T cell cytotoxic function, and proximal TCRmediated kinase activation. Interestingly, TRAF3 was recruited to the TCR complex upon TCR plus CD28 stimulation, demonstrating the association of TRAF3 with the TCR complex (Xie et al., 2011a) . Notably, the potential roles of TRAF3 in other aspects of T cell biology have not been characterized.
Invariant NK T (iNKT) cells are impor tant regulators in a variety of immune diseases (Vincent et al., 2003; Taniguchi et al., 2003; Bendelac et al., 2007 , Scanlon et al., 2011 . They possess several unique features that distinguish them from other immune cells, including expres sion of an invariant TCR chain, both T cell and NK cell markers, and production of copious amounts of cytokines very rapidly upon stimu lation. Their four developmental stages (stages 0-3) are also distinctive, with different recep tormediated signals and sets of transcription factors required for progression through each Kronenberg, 2012) . However, how the transition between sig nals from early to later stages is finely regulated to promote iNKT cell development remains ill defined. In this study, we identify TRAF3 as an essential regulator of iNKT cell devel opment and function by modulating events dependent on the strength of TCR signaling.
stage (Borowski and Bendelac, 2005; Das et al., 2010; D'Cruz et al., 2010) . TCR signaling in conjunction with the SLAM (signaling lymphocyticactivation molecule) is essential for early stage iNKT cell development, whereas IL15 signaling is absolutely required for terminal expansion and maturation (Godfrey and Berzins, 2007; Godfrey et al., 2010; Engel and 
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BM chimeric mice by transferring a 1:1 ratio of BM from C57BL/6 mice (WT, CD45.1 + ) and TTRAF3 / mice (CD45.2 + ), into lethally irradiated WT mice (CD45.1 + CD45.2 + ). 8 wk later, analysis of recipients showed that the percentage of iNKT cells developing from TTRAF3 / BM was 10fold less than from WT BM in all lymphoid organs examined, whereas the percentage of CD4 + and CD8 + T cells was not different (Fig. 1, F and G) . Similar results were obtained with 1:20 or 20:1 ratios of mixed BM (unpublished data). In addition, the expression levels of CD1d, CD150, and Ly108 on doublepositive thymocytes were not different between TTRAF3 / and littermate control (LMC) mice (unpublished data). To determine whether this is a TRAF3 specific cellautonomous effect, TTRAF3 / BM was trans duced with a virus expressing the traf3 gene and transplanted into sublethally irradiated Rag1 deficient (Rag1 / ) mice. Analysis of these mice 8 wk after reconstitution showed that forced expression of TRAF3 significantly increased the per centage of iNKT cells, but empty viral vector had no effect (Fig. 1 H) . These results demonstrate that TRAF3 affects iNKT cell development in a cellintrinsic manner.
TRAF3 affects iNKT cell development after positive selection
It is well established that iNKT cell development in the thy mus undergoes four distinct stages (Godfrey, et al., 2010) . The presence of a few thymic iNKT cells in TTRAF3 / mice allowed us to estimate at which stages TRAF3 exerts its effect. With enriched thymic iNKT cells, we observed 10fold fewer absolute numbers of iNKT cells in TTRAF3 / than in LMC mice. However, the percentage of stage 0 and stage 1 iNKT cells was more than sevenfold higher, and for stage 2 was twofold higher; in contrast, the percentage of INKT cells in stage 3 was lower in TTRAF3 / mice than in LMC mice (Fig. 2 A) . Therefore, the absolute number of iNKT cells in stage 2 and, in particular, stage 3 was drastically reduced, RESULTS AND DISCUSSION TRAF3 is required for iNKT cell development Studies of the TTRAF3 / mouse demonstrate that TRAF3 plays an essential role in T cell function and enhances TCR/ CD28 signaling. Interestingly, although mature conven tional T cells show striking functional defects in the absence of TRAF3, they develop normally and are present in normal numbers (Xie et al., 2011a) . In contrast, we observed that TTRAF3 / mice exhibited an 10fold decrease in iNKT cells in the thymus and liver, and a twofold decrease in spleen in both percentage and total number (Fig. 1, A and B) . Thus, in the current study, we investigated the role of TRAF3 in the development and function of iNKT cells. Together with re duced iNKT cell numbers, there was remarkably less IFN and IL4 produced by TRAF3deficient iNKT cells upon in vivo stimulation with galactosylceramide (GalCer; Fig. 1 C) . These observations led us to hypothesize that TRAF3 plays a distinct role in the development of iNKT cells, com pared with conventional  T cells (Xie et al., 2011a) .
LckCre mediates depletion of floxed genes from as early as the DN2 T cell developmental stage in the thymus (Lee et al., 2001) , earlier than that mediated by CD4Cre. To ex amine the possibility that the presence of a few iNKT cells in TTRAF3 / mice might result from residual TRAF3 protein when iNKT cells start developing, we crossed TRAF3 flox/flox mice with LckCre mice. TRAF3 was completely depleted from the DN3 stage in Lck Cre Traf3 flox/flox mice, demonstrated by Western blot (Fig. 1 D) . With this new mouse model, we found that iNKT cells were reduced to similar levels as in the CD4Cre TTRAF3 / mouse ( Fig. 1 E) . This result implies that TRAF3's role is important at very specific stages during iNKT cell development.
TRAF3 affects iNKT development in a cell-intrinsic manner
To explore whether defective iNKT cell development in TTRAF3 / mice is a cellautonomous effect, we generated iNKT cells can be regulated by Tbet (Townsend et al., 2004; Matsuda et al., 2007) , we first examined the expression level of Tbet and CD122. Flow cytometry data showed that ex pression of Tbet is remarkably reduced (Fig. 3 A) , as is CD122 (Fig. 3 B) in TRAF3 / thymic iNKT cells. Notably, Tbet or CD122 exhibited only basal level expression at stages 0 and 1 but were drastically upregulated in stages 2 and 3 in LMC mice, consistent with the distinct roles of TCR and IL15 signaling in different stages of iNKT development and matu ration. To investigate whether the reduction of Tbet and CD122 affected IL15-mediated proliferation of iNTK cells, thymocytes depleted of CD8 + T cells were CFSE labeled and incubated with IL15 for 4 d. Assessment of CFSE dilution by flow cytometry showed much lower cell proliferation in TRAF3 / than in LMC stages 2 and 3 iNKT cells (Fig. 3 C) . IL15-induced phosphorylation of STAT5 was also impaired in TTRAF3 / iNKT cells (Fig. 3 D) . These results indicate that TRAF3 deficiency impairs IL15-mediated proliferation of iNKT cells by reducing Tbet and CD122 expression.
BclxL is a major target of IL15 signaling and essential for maintaining iNKT cell survival (Gordy et al., 2011) . Ex amination of BclxL expression in TTRAF3 / mice shows that stage 3 thymic iNKT cells expressed much less than LMC (Fig. 3 E) . To explore whether this results in impaired survival, we estimated survival status of iNKT cells in vitro. Upon tet ramer stimulation, stage 3 TTRAF3 / iNKT cells under went much faster cell death at all time points examined, but whereas the numbers in stage 0 and 1 were relatively normal or just slightly reduced in TTRAF3 / mice (Fig. 2 B) . This result indicates that TRAF3 is not essential for precursor se lection (stage 0) and transition from stage 0 to 1 but is critical for the burst proliferation from stage 1 to stages 2 and 3. Consistent with this observation, there was reduced prolifera tion of iNKT cells at stages 1 and 2 in TTRAF3 / mice (Fig. 2 C) . These results, in conjunction with findings in Lck Cre TRAF3 flox/flox mice that TRAF3 deficiency did not completely block iNKT cell development, indicate that the involvement of TRAF3 in iNKT cell development is stage specific. We next explored whether the expression level of traf3 differs in distinct stages. Results indicate that traf3 gene expression increased during iNKT cell development, being highest in stage 3 and lowest in stages 0 and 1 (Fig. 2 D) . The expression level of traf3 suggests that TRAF3 might play a more important role in mature iNKT cells.
Defective response of TRAF3-deficient iNKT cells to IL-15 stimulation
IL15 is important in terminal stage expansion, maturation, and homeostasis of iNKT cells (Matsuda et al., 2002; Castillo et al., 2010; Gordy et al., 2011) . Our observations with TTRAF3 / mice share similarities with the phenotypes reported for IL15-deficient mice, which encouraged us to explore whether TRAF3 deficiency affects IL15-mediated iNKT cell expan sion and homeostasis. Because the expression of CD122 on 
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results support our hypothesis that TRAF3 is required for optimal TCR signaling to upregulate Tbet expression dur ing the transition from stages 1 to 2. To assess whether defec tive Tbet expression is responsible for impaired iNKT cell development, Tbet overexpression by retroviral transduction in BM chimeric mice showed that the percentage of iNKT cells was dramatically increased in Tbet-overexpressing cells, com pared with virusnegative cells or those transduced with viral vector only. Consistently, CD122 expression was also increased in Tbet-overexpressing cells (Fig. 4, C and D) . This result indi cates that Tbet overexpression can rescue defective iNKT cell development induced by TRAF3 deficiency.
TRAF3-deficient iNKT cells are functionally impaired
During iNKT cell development, stage 2 immature cells migrate into the periphery, further mature into functional iNKT cells, and acquire NK cell surface markers. Analysis of cell surface markers of splenic iNKT cells showed that they are either slightly to moderately decreased or unchanged (Fig. 5 A) , in dicating that a few iNKT cells can still mature in the absence of TRAF3. To investigate whether the function of these ma ture iNKT cells is impacted by TRAF3 deficiency, cytokine production by peripheral iNKT cells stimulated with GalCer was examined. Intracellular staining revealed that the percent age of TRAF3 / iNKT cells producing IFN and IL4 was markedly reduced compared with LMC iNKT cells (Fig. 5 B) . Results from BM chimera mice showed that defective IFN and IL4 production by TRAF3 / iNKT cells was a cell intrinsic defect (unpublished data). This result is comparable with the phenotype of TRAF3 / conventional CD4 + and CD8 + T cells, which show defective cytokine production in response to TCR stimulation (Xie, et al., 2011a) . Examination of TCR signaling showed that TRAF3 / splenic iNKT cells exhibited much less pERK and pp38 after tetramer stimu lation than LMC iNKT cells (Fig. 5 C) . These results indicate that TRAF3 is also required for TCR signaling during mature iNKT cell function.
this was confined to stage 3 of maturation (Fig. 3 F) . Similarly, more cell death was found in TRAF3 / iNKT cells without stimulation (unpublished data). These results suggest that re duced expression of BclxL could contribute to decreased iNKT cell number in TTRAF3 / mice. Collectively, TRAF3 deficiency led to a failure to upregulate Tbet and CD122 and further impaired both IL15 mediated terminal expan sion and survival of iNKT cells.
TRAF3 is required for T-bet up-regulation by impacting TCR signaling during iNKT cell development
Upregulation of Tbet can be initiated and maintained by TCR signaling (Bajénoff, et al., 2002; Matsuoka, et al., 2004) in synergy with IFN/STAT1 signaling (Lighvani, et al., 2001; Afkarian, et al., 2002) . Our previous report that TRAF3 is required for normal levels of TCR signaling in conven tional T cells (Xie et al., 2011a) prompted us to hypothesize that defective upregulation of Tbet during the transition from stage 1 to stage 2 results from reduced strength of TCR signaling. With optimized stimulation by PBS57CD1d tetra mer and staining conditions, we found that phosphorylation of the MAP kinases ERK and p38 was detectable in LMC iNKT cells within 2-5 min of tetramer stimulation. However, ERK phosphorylation at all stages of TTRAF3 / iNKT cell development was defective compared with that seen in LMC iNKT cells (Fig. 4 A) . Similar results were obtained for pp38 (unpublished data). To verify that weakened TCR signaling was responsible for reduced Tbet expression, mice were treated with antiCD3 Ab. 18 h later, thymic iNKT cells were enriched and stained for Tbet. Results show that Tbet expression was markedly increased in stage 1 of LMC iNKT cells, which was equal to the level in stages 2 and 3 in untreated control iNKT cells. However, there was only minimal upregulation of Tbet in TTRAF3 / iNKT cells after antiCD3 Ab treatment (Fig. 4 B) . Notably, Tbet expression in stages 2 and 3 was not further upregulated upon stimulation in LMC iNKT cells, indicating that it reaches its peak levels at these stages. These into mice. Serum was collected at 2 and 5 h after injection. IFN and IL4 were measured by ELISA according to the manufacturer's instructions (ELISA ReadySETGo; eBioscience). For secondary activation of B cells, splenocytes were collected 5 h after injection and stained with antibodies against CD69 and B220. To detect cytokine production by single cells, sple nocytes were isolated at 1.5 h after GalCer injection and incubated with Brefeldin A in vitro for another 2 h. Intracellular staining for IL4 and IFN was performed using Cytofix/Cytoperm reagents (BD).
Retrovirus transduction and bone marrow chimeras. Recipient CD45.1 + CD45.2 + congenic C57BL/6 mice were given 1,100 rad irradia tion 16 h before transfer. BM cells harvested from the tibiae and femurs of TTRAF3 / (CD45.2 + ) and WT (CD45.1 + ) mice were depleted of B220 + and CD3 + cells by magnetic bead separation (Milteyni Biotec). 5 × 10 6 cells from each mouse strain were mixed and injected intravenously into recipi ent mice.
For virus packaging, the mouse traf3 or Tbx21 gene was cloned and in serted into the retrovirus backbone pMIG. pMIG,pMIGtraf3 or pMIG Tbx21 and helper vector pCLECO were cotransfected into 293T epithelial cells using lipofectamine (Invitrogen). Supernatant was harvested after 48 h. Lineagenegative BM cells were purified using a kit (Milteyni Biotec), stimu lated overnight with a cytokine combination (IL6, IL3, and SCF [PeproTech]), and transduced with viral supernatant. Rag1 / mice were sublethally irradi ated with 500 rad irradiation and rested overnight. 0.5 × 10 6 transduced BM cells were transferred by i.v. injection. The resulting chimeras were ana lyzed 8 wk later.
Flow cytometry. Singlecell suspensions were prepared from thymi and spleens, and erythrocytes were lysed. Liver mononuclear cells were isolated (Xie et al., 2011a) . For flow cytometry staining, nonspecific Ab binding was blocked with anti-mouse CD16/CD32 mAb and cells stained with fluores cently labeled antibodies against TCR (H57597), CD4 (L3T4), CD8 (53-6.7), B220 (RA36B2), CD24 (M1/69), CD44 (IM7), NK1.1 (PK136), CD69 (H1.2F3), CD25 (eBio7D4), NKG2D (A10), CD49b (DX5), CD1d (1B1), CD45.2 (104), CD45.1 (A20), CD122 (TMb1), IL4 (BVD624G2), IFN (XMG1.2), Tbet (eBio4B10), SLAM6 (13G319D), and CD150 (9D1). For BclxL staining, cells were stained with anti-BclxL Ab (54H6) followed by anti-mouse-APC secondary Ab. All antibodies were purchased from eBioscience, BD, or Cell Signaling Technology. For intracellular staining of Tbet and BclxL, cells were first stained for surface markers, fixed and permeabilized with the Foxp3 Staining Buffer Set (eBioscience), and stained
The stagespecific effect of TRAF3 on iNKT cell devel opment suggests that TRAF3 is a key connector between TCR and IL15 signaling. TRAF3 deficiency didn't completely block the development of stages 2 and 3, indicating the in volvement of additional regulators in the transition stages. Defective iNKT cell development is consistent with our find ings that the percentage of memory (CD44 Hi CD122 Hi ) CD8 + T cells is decreased in TTRAF3 / mice (unpublished data). These defects in both iNKT cells and CD8 + T cells indicate that they might share similar mechanisms. One possibility is that when they become mature T cells with downregulation of CD24, TRAF3 plays more important roles in optimizing TCR signaling. Our findings also raise future questions: why is TRAF3 required for iNKT cell but not conventional T cell development? Does TRAF3 play distinct roles in different T cell subsets? Precisely how does TRAF3 participate in proxi mal TCR signaling? All are the focus of our ongoing studies. The findings of this study reveal TRAF3 to have rheostat func tion in modulating TCR signal strength. Our results high light the diverse roles played by TRAF3 in different immune cells and the importance of TRAF3 in multiple aspects of T cell biology.
MATERIALS AND METHODS
Animals. TRAF3 flox/flox mice were previously described and backcrossed with C57BL/6 mice for 10 generations. TRAF3 flox/flox mice were bred with CD4 Cre mice (Taconic) and Lck Cre mice (The Jackson Labo ratory). CD45.2 + C57BL/6 and congenic CD45.1 + C57BL/6 mice (The Jackson Laboratory) were bred to generate CD45.2 and CD45.1 double positive mice. Rag1 / mice were provided by F. Sutterwala (University of Iowa, Iowa City, IA). Mice of 6-12 wk of age were used for all experiments. All mice were maintained in facilities under specific pathogenfree condi tions at The University of Iowa and were used in accordance with National Institutes of Health guidelines under an animal protocol approved by the Animal Care and Use Committee of the University of Iowa.
Cytokine detection. For serum cytokine detection, 5 µg GalCer (Avanti Polar Lipids, Alabaster, AL) in 100 µl PBS was injected intraperitoneally with relevant Abs. For thymic iNKT cell purification, thymocytes were stained with PElabeled PBS57CD1d tetramer, followed by antiPE beads and purified with a magnetic column (Milteyni Biotec). Alternatively, thymic iNKT cells were enriched by depleting CD8 + cells, using PElabeled anti CD8 Ab and antiPE beads. BrDU in vivo incorporation was measured according to the manufacturer's instructions (BrDU Flow kit; BD). Flow cytometric analysis and cell sorting were performed using a FACS LSRII or Aria (BD) at The University of Iowa Flow Cytometry Facility. Results were analyzed with FlowJo software (Tree Star).
In vitro survival assay. Enriched thymic iNKT cells were stained with or without PBS57CD1d tetramer and incubated in complete RPMI medium. Samples were taken at various time points and stained for cell surface markers and then stained with FITClabeled Annexin V (eBioscience) in Annexin V binding buffer for 15 min. Finally, propidium iodide (PI) was added and cells were analyzed by flow cytometry without fixation.
In vitro proliferation assay. Thymocytes depleted of CD8 + cells were la beled for 10 min with 10 µM CFSE in accordance with manufacturer's in structions (Invitrogen). IL15 was added at indicated concentrations and cells were incubated in complete medium for 4 d. CFSE dilution was analyzed by flow cytometry.
TCR signaling induced by PBS57-CD1d tetramer. Thymic iNKT cells enriched at 4°C with PElabeled PBS57CD1d tetramer or splenocytes stained with tetramer were incubated in a 37°C water bath for 2 or 5 min. Cells were fixed immediately with 4% paraformaldehyde for 10 min at room temperature, washed, and permeabilized with 0.1% Triton X100 for 5 min. Surface staining was performed after washing, followed by intracellular stain ing for phosphoERK or phosphop38 (Cell Signaling Technology). Cells were analyzed by flow cytometry.
In vivo stimulation with anti-CD3 Ab. For Tbet upregulation experi ments, LMC or TTRAF3 / mice were injected intravenously with 25 µg antiCD3 Ab (2C11; eBioscience). Thymic iNKT cells were enriched after 18 h and surfacestained for CD24, NK1.1, and CD44, followed by intracel lular staining for Tbet. Cells were analyzed by flow cytometry.
Cell sorting and Western blots. Thymocytes from Lck Cre TRAF3 flox/flox mice were stained and sorted for DN1, DN2, and DN3. Cell lysates were separated by 10% SDSPAGE and transferred to PVDF membranes. Anti TRAF3 (M20) and antiactin (C2; Santa Cruz Biotechnology, Inc.) Abs were used for TRAF3 and actin detection.
Real-time PCR. Different stages of thymic iNKT cells were sorted. RNA was extracted with RNeasy Protocol (QIAGEN) and cDNA synthesized using SuperScript II (Invitrogen). RTPCR was performed on an ABI PRISM 7900 Sequence Detection System (Applied Biosystems) using SYBR Green (Applied Biosystems). cDNA levels were determined with a standard curve and normalized to actin. TRAF3 primers were: forward 5GAGCAAGGAG GCTACAAGGAG3 and reverse 5CATGCAGCTCTCGCAGAAC3; actin primers were: forward 5TGGCACCCAGCACAATGAA3 and reverse 5CTAAGTCATAGTCCGCCTAGAAGCA3.
IL-15 signaling. Thymocytes depleted of CD8 + T cells or splenocytes were incubated with IL15 for 20 min. They were fixed immediately with 4% paraformaldehyde for 10 min at room temperature, washed, and permeabi lized with 0.1% Triton X100 for 5 min. Surface staining was performed with antiNK1.1 and TCR Abs after washing. Phosphorylation of STAT5 was de tected with antipSTAT5 Ab (D47E7; Cell Signaling Technology). Cells were analyzed by flow cytometry.
Statistics. Data represent mean ± SEM. Statistical comparisons of differ ences between sample means used Student's t test.
